Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04116736
Other study ID # CR-6334
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 19, 2019
Est. completion date March 10, 2023

Study information

Verified date March 2023
Source Johnson & Johnson Vision Care, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This registry study is a one-year, one-visit, observational, prospective, open-label, two-arm, multi-center, multi-national, post-market study of approximately 300 patients who have recently been fitted with the ACUVUE® OASYS with Transitions™ and approximately 300 patients who have recently been fitted with spherical nonphotochromic reusable marketed silicone hydrogel contact lenses (of any brand). Eligible subjects will be asked to complete a Patient Registration Questionnaire several times throughout the year.


Recruitment information / eligibility

Status Completed
Enrollment 146
Est. completion date March 10, 2023
Est. primary completion date March 10, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Potential subjects must satisfy all of the following criteria to be enrolled in the study: - Contact lens neophytes or those who have recently (i.e. within last 2 months) begun the use of a new lens type and have purchased a supply of lenses. - A minimum age of 18 years, with no maximum age. - The registrant must read and sign the Informed Consent form. - The registrant must appear able and willing to adhere to the instructions set forth in this clinical protocol. Exclusion Criteria: - Potential subjects who meet any of the following criteria will be excluded from participating in the study: - Current participant in another research study. - Employee or relative of site, or family member of Recruiting Practitioner or Johnson & Johnson. - Non-spherical contact lens wearers, i.e. toric or multifocal lenses.

Study Design


Related Conditions & MeSH terms

  • Vision Satisfaction in Bright Light

Intervention

Device:
ACUVUE® OASYS with Transitions™
JJVC Marketed Contact Lens
Silicone Hydrogel Contact Lens
Any reusable spherical silicone hydrogel brand that is approved and marketed in the country conducting the study.

Locations

Country Name City State
Spain Optica Ronda Almeria
Spain Natural Optics Balaguer Balaguer
Spain Sanchez Rubal Ltd - Finisterre La Coruna
Spain Sanchez Rubal Ltd. - Sanchez Bregua La Coruna
Spain Centro Optico Raga Linares
Spain Centro Boston de Optometria Madrid
Spain Centro Optico Montero Madrid
Spain Cirugia Ocular de Madrid Madrid
Spain Opticalia Real Villa Madrid
Spain Opticas ClaraVision Ontinyent
Spain Centro Optico Sevilla
United Kingdom Chalmers Opticians Ltd Cardiff Wales
United Kingdom First Contact Opticians Ltd. Eastcote Middlesex
United Kingdom Auckland Opticians Horbury Wakefield
United Kingdom Urquhart Opticians Ltd Kilmarnock Scotland
United Kingdom Eyes On the Common Ltd. London England
United Kingdom Hodd Barnes Dickens Ltd London England
United Kingdom P Shah Opticians London England
United Kingdom Leightons Insight Marlow Marlow Buckinghamshire
United Kingdom Eyesite Opticians Reading Berkshire
United Kingdom Eyesite Opticians Weybridge Surrey
United Kingdom Eyesite Opticians Winchester Hampshire

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Vision Care, Inc.

Countries where clinical trial is conducted

Spain,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vision Satisfaction in Bright Lighting Subjects will be asked to evaluate their vision satisfaction in bright lighting by rating their level of agreement with the statement "I was satisfied with the quality of my vision in bright lighting with these contact lenses" using a 5-point agreement Likert scale (1: Strongly Disagree, 2: Disagree, 3: Neither Agree nor Disagree, 4: Agree and 5: Strongly Agree). up to 12-month follow-up
Secondary Overall quality of vision This will be assessed subjectively using the item "I am satisfied with the overall quality of my vision with these contact lenses". The item uses a 5-point agreement scale (1: Strongly Disagree to 5: Strongly Agree). up to 12-month follow-up
Secondary Pulfrich Effect This will be assessed subjectively using the item "While wearing these lenses, my depth perception of moving objects has NOT been impacted". Subjects who disagree or strongly disagree with the statement will be considered to have experienced the Pulfrich effect. up to 12-month follow-up
Secondary Overall comfort This will be assessed using the item "How would you rate the overall comfort of these contact lenses?". The item uses the 5-point satisfaction scale, 1: Excellent, 2: Very Good, 3: Good, 4:
Fair and 5: Poor.
up to 12-month follow-up
Secondary Reported serious and significant ocular adverse events Incidence rate serious and significant ocular adverse events during the study period will be calculated (in 100 patient-year) using all available data from the entire study. up to 12-month follow-up